SCHEMBL8099332

SCHEMBL8099332

CCCCCCCCCCCCCCCCOC(=O)CNC(=O)Oc1ncc(C(=O)NS(=O)(=O)c2ccccc2)cc1OC

nearest known ligand 0.41

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 1/20 0.41
KMT2A Q03164 1/20 0.41
SMPD1 P17405 4/20 0.40
PTGS1 P23219 1/20 0.40
PTGS2 P35354 1/20 0.40
S1PR3 Q99500 4/20 0.40
S1PR1 P21453 2/20 0.40
EGFR P00533 1/20 0.39
P4HTM Q9NXG6 2/20 0.39
KAT6A Q92794 1/20 0.39
EPHX2 P34913 1/20 0.38
BCL2L1 Q07817 1/20 0.38
MCL1 Q07820 1/20 0.38
PPARG P37231 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8104048 0.90 PTGS2 (0.44) KMT2APTGS1PTGS2EGFRP4HTM
SCHEMBL8875058 0.88 MEN1 (0.45) MEN1KMT2ASMPD1PTGS1PTGS2
SCHEMBL8104049 0.87 LMNA (0.39) MEN1KMT2AEPHX2PPARG
SCHEMBL8766943 0.85 PTGS2 (0.48) PTGS1PTGS2EGFRP4HTMMCL1
SCHEMBL8098997 0.85 PPARG (0.45) MEN1KMT2ASMPD1PPARG
SCHEMBL8810655 0.82 MEN1 (0.44) MEN1KMT2A
SCHEMBL8809005 0.82 MEN1 (0.44) MEN1KMT2A
SCHEMBL8807170 0.82 MEN1 (0.44) MEN1KMT2A
SCHEMBL8806163 0.82 MEN1 (0.44) MEN1KMT2A
SCHEMBL8806666 0.82 MEN1 (0.44) MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0673932-B1 Sulfonamidocarbonyl-pyridine-2-carboxamides as well as their pyridine-N-oxides, process for their preparation and their use as medicaments HOECHST AG (DE) 2000-06-07 EP disclosed
EP-0673932-A1 Sulfonamidocarbonyl-pyridine-2-carboxamides as well as their pyridine-N-oxides, process for their preparation and their use as medicaments HOECHST AKTIENGESELLSCHAFT (DE) 1995-09-27 EP disclosed